Author:
Murthy Sreenivasa,Aneja Pankaj,Asirvatham Arthur Joseph,Husemoen Lise Lotte N.,Rhee Nicolai A.,Kesavadev Jothydev
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference30 articles.
1. Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. https://doi.org/10.1016/j.diabres.2018.02.023 (PubMed PMID: 29496507).
2. International Diabetes Federation. IDF Diabetes Atlas 8th edition 2017. http://www.diabetesatlas.org/. Accessed 27 Feb 2019.
3. Home P, Riddle M, Cefalu WT, et al. Insulin therapy in people with type 2 diabetes: opportunities and challenges? Diabetes Care. 2014;37(6):1499–508. https://doi.org/10.2337/dc13-2743 (PubMedPMID: 24855154; PubMed Central PMCID: PMCPMC5131884).
4. Mohan V, Kalra S, Kesavadev J, et al. Consensus on initiation and intensification of premix insulin in type 2 diabetes management. J Assoc Physicians India. 2017;65(4):59–73 (PubMed PMID: 28527166).
5. Kalra S, Balhara YP, Sahay BK, et al. Why is premixed insulin the preferred insulin? Novel answers to a decade-old question. J Assoc Physicians India. 2013;61(1 Suppl):9–11 (PubMed PMID: 24482980).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献